hiv-infections

Documents about hiv-infections

• Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women#847955ClinicalTrials.gov
• Acceptability and preferences regarding long-acting injectable antiretroviral therapy among people with HIV in Pakistan.#9911PubMed
• Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults#148560ClinicalTrials.gov
• A Phase I Safety and Immunogenicity Trial of UBI SynVac (HIV-1 MN Octameric V3 Peptide Vaccine)#307307ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides#844740ClinicalTrials.gov
• The Prevention Options for Women Evaluation Research (POWER) Cohort#847456ClinicalTrials.gov
• Quality of Life, Depression and Sexual Function in Men Living With HIV#851191ClinicalTrials.gov
• Growth Hormone Treatment of Children With HIV-Associated Growth Failure#852182ClinicalTrials.gov
• Effect of a Psychological Intervention on Antiretroviral Therapy and Mental Health Outcomes in HIV-positive Adults in Zimbabwe#866141ClinicalTrials.gov
• The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine#884739ClinicalTrials.gov
• Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia#886736ClinicalTrials.gov
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma#887936ClinicalTrials.gov
• BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes#893663ClinicalTrials.gov
• Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily#894714ClinicalTrials.gov
• Study of MDW Levels Predicting the Development of Sepsis in Hospitalized HIV-infected Patients and Correlation With Prognosis#903078ClinicalTrials.gov
• The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia#904093ClinicalTrials.gov
• Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs#901545ClinicalTrials.gov
• Digital Community to Improve Health in Rural Areas#174951ClinicalTrials.gov
• Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females#398195ClinicalTrials.gov
• Bioequivalence Study to Compare Dolutegravir 50mg Film-coated Tablets#801454ClinicalTrials.gov
• A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea#812945ClinicalTrials.gov
• Characteristics and Outcomes of TB and HIV Co-infections#907350ClinicalTrials.gov
• Contraceptive eligibility for women at high risk of HIV: guidance statement: recommendations on contraceptive methods used by women at high risk of HIV#376867WHO IRIS
• Improving Care and Community Representation for Adolescents and Young Adults Living With HIV in West Africa#843872ClinicalTrials.gov
• The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)#850015ClinicalTrials.gov
• Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania#869511ClinicalTrials.gov
• Study of Pharmacokinetics in HIV-infected Women#893061ClinicalTrials.gov
• Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection#903715ClinicalTrials.gov
• A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults#904398ClinicalTrials.gov
• Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study#828165ClinicalTrials.gov
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults#623543ClinicalTrials.gov
• Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome#848603ClinicalTrials.gov
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)#872610ClinicalTrials.gov
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection#881573ClinicalTrials.gov
• Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure#836627ClinicalTrials.gov
• Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)#836961ClinicalTrials.gov
• Cryptococcal Antigen Screening Plus Sertraline#846511ClinicalTrials.gov
• A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients#18700ClinicalTrials.gov
• Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS#154784ClinicalTrials.gov
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities#180353ClinicalTrials.gov
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160#407779ClinicalTrials.gov
• Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis#803916ClinicalTrials.gov
• Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi#804474ClinicalTrials.gov
• Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV#811254ClinicalTrials.gov
• VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1#828958ClinicalTrials.gov
• Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women#831323ClinicalTrials.gov
• A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247)#859303ClinicalTrials.gov
• Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk Networks#872449ClinicalTrials.gov
• Episodic Acyclovir Therapy for Genital Ulcers#874802ClinicalTrials.gov